AU1487888A - Method for therapy of leukemias and certain other malignancies - Google Patents
Method for therapy of leukemias and certain other malignanciesInfo
- Publication number
- AU1487888A AU1487888A AU14878/88A AU1487888A AU1487888A AU 1487888 A AU1487888 A AU 1487888A AU 14878/88 A AU14878/88 A AU 14878/88A AU 1487888 A AU1487888 A AU 1487888A AU 1487888 A AU1487888 A AU 1487888A
- Authority
- AU
- Australia
- Prior art keywords
- leukemias
- malignancies
- therapy
- certain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
- A61K38/2026—IL-4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
- A61K38/2006—IL-1
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
- A61K38/2013—IL-2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
- A61K38/202—IL-3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
- A61K38/2033—IL-5
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
- A61K38/204—IL-6
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- A61K38/217—IFN-gamma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2851—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the lectin superfamily, e.g. CD23, CD72
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2866—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2878—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the NGF-receptor/TNF-receptor superfamily, e.g. CD27, CD30, CD40, CD95
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE8701004 | 1987-03-11 | ||
SE8701004A SE8701004D0 (en) | 1987-03-11 | 1987-03-11 | METHOD FOR THERAPY OF LEUKEMIAS AND CERTAIN OTHER MALIGNANCIES |
Publications (2)
Publication Number | Publication Date |
---|---|
AU1487888A true AU1487888A (en) | 1988-10-10 |
AU621046B2 AU621046B2 (en) | 1992-03-05 |
Family
ID=20367826
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU14878/88A Ceased AU621046B2 (en) | 1987-03-11 | 1988-03-10 | Method for therapy of leukemias and certain other malignancies |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP0305468A1 (en) |
JP (1) | JPH01502592A (en) |
AU (1) | AU621046B2 (en) |
FI (1) | FI885177A0 (en) |
SE (1) | SE8701004D0 (en) |
WO (1) | WO1988006891A1 (en) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ226799A (en) * | 1987-11-06 | 1991-08-27 | Oncogen | Breast cancer inhibitory factor and method for inhibiting proliferation of neoplastic cells and compositions therefor |
GB8808015D0 (en) | 1988-04-06 | 1988-05-05 | Ritter M A | Chemical compounds |
JPH0611706B2 (en) * | 1989-01-20 | 1994-02-16 | ザ ユニバーシティ オブ メルボルン | Fibrin lysis |
JP2704546B2 (en) * | 1989-04-04 | 1998-01-26 | 光利 太良 | ATLL therapeutic inhalant |
KR100191223B1 (en) * | 1989-07-28 | 1999-06-15 | 둘락 노먼 씨. | Method for purifying interleukin-4 and pharmaceutical composition comprising them |
FR2653020B1 (en) * | 1989-10-17 | 1993-03-26 | Roussel Uclaf | USE OF A POLYPEPTIDE HAVING THE ACTIVITY OF HUMAN INTERLEUKIN 2 FOR THE PREPARATION OF PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF LEUKEMIA. |
GB9001625D0 (en) * | 1990-01-24 | 1990-03-21 | Ciba Geigy Ag | A pharmaceutical preparation for maturation of prothymocytes |
GB9010356D0 (en) * | 1990-05-09 | 1990-06-27 | Ciba Geigy Ag | Maturation of hemopoietic cells |
AU9052591A (en) * | 1990-11-16 | 1992-06-11 | Schering Corporation | Method for increasing and activating monocytes and neutrophils and for inducing maturation of myeloid cells with interleukin-5 |
MX9205233A (en) * | 1991-09-16 | 1993-12-01 | Schering Corp | USE OF IL-5 TO TREAT SOLID TUMORS. |
NZ278740A (en) * | 1993-12-23 | 1998-05-27 | Immunex Corp | Treating disease characterised by neoplastic cells expressing cd40 using a cd40 binding protein |
US7033589B1 (en) | 1997-02-20 | 2006-04-25 | Biogen Idec Ma Inc. | γ-1 anti-human CD23 monoclonal antibodies and use thereof as therapeutics |
US6893636B2 (en) | 1997-02-20 | 2005-05-17 | Biogen Idec Ma Inc. | Gamma-1 and gamma-3 anti-human CD23 monoclonal antibodies and use thereof as therapeutics |
US20050136055A1 (en) | 2003-12-22 | 2005-06-23 | Pfizer Inc | CD40 antibody formulation and methods |
JP7208492B2 (en) | 2016-03-10 | 2023-01-19 | シージー オンコロジー, インコーポレイテッド | Methods of treating solid tumors or lymphoid tumors with combination therapy |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0077571A3 (en) * | 1981-10-19 | 1983-10-12 | Ajinomoto Co., Inc. | Process for producing a lymphokine |
JPH0637520B2 (en) * | 1985-07-03 | 1994-05-18 | 味の素株式会社 | Polypeptide |
US4882282A (en) * | 1985-08-16 | 1989-11-21 | Immunex Corporation | DNA sequences encoding bovine interleukin-2 |
JPH0763361B2 (en) * | 1985-10-15 | 1995-07-12 | 三井東圧化学株式会社 | Cultured cell line |
PT83761B (en) * | 1985-11-19 | 1989-06-30 | Schering Biotech Corp | METHOD FOR THE PRODUCTION OF INTERLEUQUIN-4 OF MAMIFERO |
EP0256042A1 (en) * | 1986-01-15 | 1988-02-24 | AMERSHAM INTERNATIONAL plc | Interleukin |
CA1290249C (en) * | 1986-04-09 | 1991-10-08 | Cetus Corporation | COMBINATION THERAPY USING INTERLEUKIN-2 AND/OR INTERFERON-.beta. AND TUMOR NECROSIS FACTOR |
AU603820B2 (en) * | 1986-08-13 | 1990-11-29 | Takeda Chemical Industries Ltd. | Antitumor agent |
-
1987
- 1987-03-11 SE SE8701004A patent/SE8701004D0/en unknown
-
1988
- 1988-03-10 EP EP88902603A patent/EP0305468A1/en not_active Withdrawn
- 1988-03-10 WO PCT/SE1988/000118 patent/WO1988006891A1/en not_active Application Discontinuation
- 1988-03-10 JP JP63502593A patent/JPH01502592A/en active Pending
- 1988-03-10 AU AU14878/88A patent/AU621046B2/en not_active Ceased
- 1988-11-10 FI FI885177A patent/FI885177A0/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
EP0305468A1 (en) | 1989-03-08 |
JPH01502592A (en) | 1989-09-07 |
FI885177A (en) | 1988-11-10 |
AU621046B2 (en) | 1992-03-05 |
SE8701004D0 (en) | 1987-03-11 |
FI885177A0 (en) | 1988-11-10 |
WO1988006891A1 (en) | 1988-09-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB2202698B (en) | Microfuse and method of manufacture | |
AU7082787A (en) | Method and apparatus for iontophoretic drug-delivery | |
AU4342689A (en) | Cryoablation catheter and method of performing cryoablation | |
AU2602188A (en) | Method for preventing and treating of thrombosis | |
AU2816589A (en) | Self-regulated therapeutic agent delivery system and method | |
GB2221396B (en) | Catheters and methods of manufacture | |
AU3068684A (en) | Preparation and method for the treatment of acne | |
AU1487888A (en) | Method for therapy of leukemias and certain other malignancies | |
AU1061388A (en) | Method of excavation and apparatus therefor | |
AU2644888A (en) | Method of healing wounds in horses | |
AU3834589A (en) | Method of treating myeloid leukemias | |
GB2186192B (en) | Catheter and method of making same | |
AU1927688A (en) | Panelizing machine and method for use | |
AU6941387A (en) | Method and apparatus for improved water therapy | |
AU639371B2 (en) | Method of treating breast cancer | |
AU1503888A (en) | Method of producing iodine124 and meta-iodobenzlyguanidine containing iodine124 | |
AU1038188A (en) | Composition and method of stabilizing o-halopyridylphosphates | |
AU644197B2 (en) | Method and apparatus for improved water therapy | |
GB8812233D0 (en) | Method of treatment | |
GB8812224D0 (en) | Method of treatment | |
GB8811006D0 (en) | Method of treatment | |
GB8808915D0 (en) | Method of treatment | |
GB8822012D0 (en) | Method of treatment | |
GB8804206D0 (en) | Method of treatment | |
GB8804204D0 (en) | Method of treatment |